Skip to main content

Child PTSD Symptom Scale (CPSS)

Child PTSD Symptom Scale (CPSS)

(Foa, Johnson, Feeny, & Treadwell, 2001).

The CPSS is a 24-item self- or clinician-report measure assessing trauma symptoms in youths 8 to 18.

The CPSS can be used as a screening tool, a diagnostic tool (International Society for Traumatic Stress Studies, 2013), and to monitor symptom changes over time (Adler Nevo & Manassis, 2011). The first part of the CPSS maps onto DSM-IV criteria for PTSD. Each item is rated on a 4-point Likert scale to rate symptom severity ranging from zero (“Not at all”) to three (“5 or more times per week/almost always”). The second part of the measure focuses on functional impairment. Each item is rated from zero (“Absent”) to one (“Present”). This measure can be administered in 20 minutes by clinician and 10 minutes as a self-report measure. The CPSS can be scored manually with the first part yielding a PTSD symptom score between 0-51, and three subscale scores (i.e., re-experience, avoidance, and arousal). The first part of the CPSS demonstrates good internal consistency (α = .89), and adequate test-retest reliability of PTSD symptom severity scores over a period of one to two weeks (r = .63-.85). In addition, the CPSS demonstrates convergent validity (Foa et al., 2001) with the Child Post-Traumatic Stress Disorder Reaction Index (CPTSD–RI; Fredrick, Pynoos, & Nader, 1992) and divergent validity when compared to the DSRSC (Birleson et al., 1987) and Multidimensional Anxiety Symptom Scale (MASC; March, Parker, Sullivan, Stallings, & Conners, 1997) scores. The second part of the CPSS (functional impairment) demonstrates good internal consistency (α = .89), adequate test-retest reliability over a period of one to two weeks (r = .70) as well as a strong relationship to overall PTSD severity as compared to the CPTSD-RI (r = .42; Foa et al., 2001).

This measure can be obtained from (


Popular posts from this blog

ADVOKATE: A Tool for Assessment of Eyewitness Evidence

ADVOCATE: A Tool for Assessment of Eyewitness Evidence It is a tool designed to assess the eyewitness evidence that how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologist, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (

Diagnostic test for catatonia, the lorazepam challenge test

Benzodiazepines are the mainstay of the treatment of catatonia and are also helpful as a diagnostic probe. A positive Lorazepam Challenge Test validates the diagnosis of catatonia. After we examine the patient for signs of catatonia, 1 or 2 mg of lorazepam is administered intravenously. After 5 minutes, the patient is re-examined. If there has been no change, a second dose is given, and the patient is again reassessed (46, 78). A positive response is a marked reduction (e.g., at least 50%) of catatonic signs and symptoms, as measured with a standardized rating scale. Favorable responses usually occur within 10 min (46). If lorazepam is given intramuscularly or per os, the interval for the second dose should be longer: 15′ and 30′, respectively. Many clinicians will share the experience that a “lorazepam test” not only confirms the diagnosis of catatonia but that it also makes the underlying psychopathology apparent “by permitting mute patients to speak” (79). Analogous to the lorazepa

Classification of Depression According to the ICD-10

A first depressive episode, duration at least15 days →depressive episode (F32)  A first depressive episode, severe and rapid onset, duration less than 15 days →still depressive episode (F32) A depressive episode can be mild (2 core symptoms, 2 other symptoms from the list) (32.0) moderate (2 core symptoms, 3 or preferably 4 other symptoms) (32.1) Severe (3 core symptoms, 4 other symptoms) without psychotic symptoms (32.2) (no delusion, hallucination or stupor) Severe with psychotic symptoms (above plus either delusions, hallucinations or stupor) (F32.3) Delusions can be mood-congruent or incongruent (neutral delusions e.g. delusions of reference are considered mood incongruent. None of them count towards schizoaffective disorder unless one of the first-rank)  A mild and moderate depressive episode can be  with somatic syndrome (four or more somatic symptoms, or three very severe somatic symptoms) without somatic syndrome (three or less somatic symptoms, not severe)  A severe depressi